The quality assurance unit failed to maintain a copy of a master schedule sheet that contained all required elements for all nonclinical laboratory studies conducted by the testing facility.
Inspection Record
Center for Translational Medicine — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The final study report did not include a description of all circumstances that may have affected the quality or integrity of the data.
Standard operating procedures have not been established for test system observations and handling of (b) (4) (b) (4) or (©) (4) during study.
The study director failed to assure that all raw data, documentation, protocols, specimens, and final reports were transferred to the archives during or at the close of the study.
The study director failed to assure that the protocol, including any change, was approved and was followed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.